Blog

Life sciences VC adds 2 new funds totaling $750M

andy-schwab900xx4500-3000-0-0

One of the new funds is aimed at early-stage companies; the other targets its existing companies as well as public or private investments in later-stage companies outside its portfolio.

Read More